Literature DB >> 24691653

Multiple loci associated with canine hip dysplasia (CHD) in German shepherd dogs.

Lena Fels1, Yvonne Marschall, Ute Philipp, Ottmar Distl.   

Abstract

Canine hip dysplasia (CHD) is the most common hereditary skeletal disorder in dogs. To identify common alleles associated with CHD, we developed 37 informative single nucleotide polymorphisms (SNPs) within 13 quantitative trait loci (QTL) previously identified for German shepherd dogs. These SNPs were genotyped in 95 German shepherd dogs affected by CHD and 95 breed, sex, and birth year-matched controls. A total of ten SNPs significant at a nominal P value of 0.05 were validated in 843 German shepherd dogs including 277 unaffected dogs and 566 CHD-affected dogs. Cases and controls were sampled from the whole German shepherd dog population in Germany in such a way that mean coancestry coefficients were below 0.1 % within cases and controls as well as among cases and controls. We identified nine SNPs significantly associated with CHD within five QTL on dog chromosomes (CFA) 3, 9, 26, 33, and 34. Genotype effects of these nine SNPs explained between 22 and 34 % of the phenotypic variance of hip dysplasia in German shepherd dogs. The strongest associated SNPs were located on CFA33 and 34 within the candidate genes PNCP, TRIO, and SLC6A3. Thus, the present study validated positional candidate genes within five QTL for CHD.

Entities:  

Mesh:

Year:  2014        PMID: 24691653     DOI: 10.1007/s00335-014-9507-1

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  17 in total

1.  Rac1 signaling stimulates N-cadherin expression, mesenchymal condensation, and chondrogenesis.

Authors:  Anita Woods; Guoyan Wang; Holly Dupuis; Zhuhong Shao; Frank Beier
Journal:  J Biol Chem       Date:  2007-06-14       Impact factor: 5.157

2.  Genetic regulation of osteoarthritis: A QTL regulating cranial and caudal acetabular osteophyte formation in the hip joint of the dog (Canis familiaris).

Authors:  Kevin Chase; Dennis F Lawler; David R Carrier; Karl G Lark
Journal:  Am J Med Genet A       Date:  2005-06-15       Impact factor: 2.802

3.  Quantitative trait loci for hip dysplasia in a cross-breed canine pedigree.

Authors:  Rory J Todhunter; Raluca Mateescu; George Lust; Nancy I Burton-Wurster; Nathan L Dykes; Stuart P Bliss; Alma J Williams; Margaret Vernier-Singer; Elizabeth Corey; Carlos Harjes; Richard L Quaas; Zhiwu Zhang; Robert O Gilbert; Dietrich Volkman; George Casella; Rongling Wu; Gregory M Acland
Journal:  Mamm Genome       Date:  2005-10-20       Impact factor: 2.957

4.  Genetic analyses of elbow and hip dysplasia in the German shepherd dog.

Authors:  K F Stock; S Klein; B Tellhelm; O Distl
Journal:  J Anim Breed Genet       Date:  2011-01-12       Impact factor: 2.380

5.  RhoA/ROCK signaling suppresses hypertrophic chondrocyte differentiation.

Authors:  Guoyan Wang; Anita Woods; Shalev Sabari; Luca Pagnotta; Lee-Anne Stanton; Frank Beier
Journal:  J Biol Chem       Date:  2004-01-15       Impact factor: 5.157

6.  Mapping quantitative trait loci for canine hip dysplasia in German Shepherd dogs.

Authors:  Yvonne Marschall; Ottmar Distl
Journal:  Mamm Genome       Date:  2007-11-20       Impact factor: 2.957

7.  Genetic ablation of Rac1 in cartilage results in chondrodysplasia.

Authors:  Guoyan Wang; Anita Woods; Hanga Agoston; Veronica Ulici; Michael Glogauer; Frank Beier
Journal:  Dev Biol       Date:  2007-04-01       Impact factor: 3.582

8.  An indication of major genes affecting hip and elbow dysplasia in four Finnish dog populations.

Authors:  K Mäki; L L G Janss; A F Groen; A-E Liinamo; M Ojala
Journal:  Heredity (Edinb)       Date:  2004-05       Impact factor: 3.821

9.  Bilaterally asymmetric effects of quantitative trait loci (QTLs): QTLs that affect laxity in the right versus left coxofemoral (hip) joints of the dog (Canis familiaris).

Authors:  Kevin Chase; Dennis F Lawler; Fred R Adler; Elaine A Ostrander; Karl G Lark
Journal:  Am J Med Genet A       Date:  2004-01-30       Impact factor: 2.802

10.  Differential genetic regulation of canine hip dysplasia and osteoarthritis.

Authors:  Zhengkui Zhou; Xihui Sheng; Zhiwu Zhang; Keyan Zhao; Lan Zhu; Gang Guo; Steve G Friedenberg; Linda S Hunter; Wendy S Vandenberg-Foels; William E Hornbuckle; Ursula Krotscheck; Elizabeth Corey; Nancy S Moise; Nathan L Dykes; Junya Li; Shangzhong Xu; Lixin Du; Yachun Wang; Jody Sandler; Gregory M Acland; George Lust; Rory J Todhunter
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

View more
  6 in total

1.  Prospective evaluation of a patented DNA test for canine hip dysplasia (CHD).

Authors:  Eberhard Manz; Bernd Tellhelm; Michael Krawczak
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

2.  Long-term genetic selection reduced prevalence of hip and elbow dysplasia in 60 dog breeds.

Authors:  A M Oberbauer; G G Keller; T R Famula
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

3.  Novel protective and risk loci in hip dysplasia in German Shepherds.

Authors:  Lea I Mikkola; Saila Holopainen; Anu K Lappalainen; Tiina Pessa-Morikawa; Thomas J P Augustine; Meharji Arumilli; Marjo K Hytönen; Osmo Hakosalo; Hannes Lohi; Antti Iivanainen
Journal:  PLoS Genet       Date:  2019-07-19       Impact factor: 5.917

4.  An across-breed validation study of 46 genetic markers in canine hip dysplasia.

Authors:  Hannes Lohi; Antti Iivanainen; Lea Mikkola; Kaisa Kyöstilä; Jonas Donner; Anu K Lappalainen; Marjo K Hytönen
Journal:  BMC Genomics       Date:  2021-01-21       Impact factor: 3.969

Review 5.  Emerging insights into the genetic basis of canine hip dysplasia.

Authors:  Mário Ginja; Ana Rita Gaspar; Catarina Ginja
Journal:  Vet Med (Auckl)       Date:  2015-05-20

6.  Genetic dissection of canine hip dysplasia phenotypes and osteoarthritis reveals three novel loci.

Authors:  Lea Mikkola; Saila Holopainen; Tiina Pessa-Morikawa; Anu K Lappalainen; Marjo K Hytönen; Hannes Lohi; Antti Iivanainen
Journal:  BMC Genomics       Date:  2019-12-27       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.